Navigation Links
Anesthesia Drug To Bring Solace To The Depressed

A single dose of an anesthesia drug provided respite from depression for a small group of patients in whom other treatments had failed, report U.S. researchers//.

The researchers however indicated that the drug, ketamine, is unlikely to be put to use in the treatment of depression because of potential side effects, which includes psychosis. But the finding does signal a new direction for future research related to depression.

Currently available antidepressants take a long time to work. Ketamine,the anaesthetic drug, is effective not only for its speed, but also because it focuses on a new system in the brain.

"It's novel because all antidepressants that are currently available work on neurotransmitters that are monoamines like dopamine and serotonin. That's the focus of the current antidepressant armamentarium,” Dr. Richard A. Friedman, director of the psychopharmacology clinic at Cornell University's Medical Center in New York City said."Ketamine involves a particular system of the brain called glutamate. It's the main excitory neurotransmitter in the brain," he added.

Depression , a disabling condition, chronic in nature, affects almost 15 million Americans, that is, 7 percent of the adult U.S. population -- in any given year. 4 percent of these patients take their own lives, resulting in 30,000 suicides per year.

Unfortunately, 50% of patients with depression don't receive treatment and, of those who do, only 40% get the best. Some don’t get better even with the best treatment.

This is one of the first studies to analyse the effect of ketamine on depression in humans, the result of which is published in the August issue of the Archives of General Psychiatry. It was observed that depression improved within a day in 71 percent of the participants who were treated with ketamine, 29 percent of whom became nearly symptom-free in a day.

Short-term side effects, including perceptio n disturbances, usually disappeared before the antidepressant effect started to make an appearance. Participants were given a relatively low dose, so they were spared the more severe side effects.

Ketamine works by blocking the N-methyl-D-aspartic acid (NMDA) receptor, which receives signals for glutamate.

The researchers are now looking at other drugs to tackle depression.


'"/>




Related medicine news :

1. Bypass Heart Surgery Performed Without General Anesthesia
2. General Anesthesia Safe For Children On Ketogenic Diet Suffering From Epilepsy
3. General Anesthesia For Heroin Detoxification Is No Good
4. Targeted Anesthesia Can Minimize Pain During Prostate Biopsy
5. Choice of Anesthesia in C-section
6. Dental Researchers Test No-Needle Anesthesia, No-Drilling Cavity Care
7. Obstetrical Anesthesia Equally Safe When Provided by CRNAs or Anesthesiologists
8. Two New Anesthesia Positions Promise to Ease Surgery Queue
9. Drug Found To Bring Relief For Individuals With Early Parkinson’
10. Improving Lighting Could Bring About A Change In Alzheimers Patients
11. Researchers Bring New Insight To Asthma And SABA Fills
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... ... January 19, 2017 , ... Wells Pharmacy Network ... of their 503A compounding pharmacy located in Ocala, Florida. , Meeting the ... patients throughout the United States for high-quality human anti-aging and wellness compounded ...
(Date:1/19/2017)... ... January 19, 2017 , ... LabRoots ... scientists from around the world, announces the launch of its newly redesigned website. ... portal to research breakthroughs and trending news, vital information on upcoming virtual events ...
(Date:1/19/2017)... ... January 19, 2017 , ... Cosmetic Town, an online plastic ... in order to make it easier for their readers to get the information they ... impact as well as the techniques used on those particular areas. , “We are ...
(Date:1/19/2017)... ... January 19, 2017 , ... Dr. ... of Dermatology and fellowship trained Mohs and cosmetic surgeon. After extensive dermatology research ... Li completed his internship in internal medicine at the Emory University and dermatology ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... who administered fillers that resulted in severe facial disfiguration. After four frightening years ... by doctors at UCLA Medical Center, who removed the substances in a partial ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Report Details What ... areas are going to grow at the fastest rates? ... assessing data, trends, opportunities and prospects. Our 190-page ... most lucrative areas in the industry and the future ... sales across the all the major categories of the ...
(Date:1/19/2017)... , Jan. 19, 2017 Report Details ... ... for Leading Companies – our new study reveals trends, ... issues and events affecting the Alzheimer,s disease therapeutics and ... answer these key questions: - How is the Alzheimer,s ...
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, ... anti-obesity drugs market is expected to grow at a CAGR ... CAGR of 38.7% in the second half of the forecast period. ... from 2016 to 2027. The market is estimated at $1,058 million ... ...
Breaking Medicine Technology: